Works matching IS 03407004 AND DT 2020 AND VI 69 AND IP 6
Results: 21
Seeking and destroying the evils from the inside-translating cancer immunity to fight COVID-19.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Advances and perspectives of dendritic cell-based active immunotherapies in follicular lymphoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 913, doi. 10.1007/s00262-020-02577-w
- By:
- Publication type:
- Article
Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1087, doi. 10.1007/s00262-020-02529-4
- By:
- Publication type:
- Article
Correction to: Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Inhibition of IDO leads to IL-6-dependent systemic inflammation in mice when combined with photodynamic therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1101, doi. 10.1007/s00262-020-02528-5
- By:
- Publication type:
- Article
Neutrophils are mediators of metastatic prostate cancer progression in bone.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1113, doi. 10.1007/s00262-020-02527-6
- By:
- Publication type:
- Article
ESTIMATE algorithm is not appropriate for inferring tumor purity and stromal and immune cell admixture in hematopoietic or stromal tumors.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 989, doi. 10.1007/s00262-020-02524-9
- By:
- Publication type:
- Article
Identification and validation of tumour microenvironment-based immune molecular subgroups for gastric cancer: immunotherapeutic implications.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1057, doi. 10.1007/s00262-020-02525-8
- By:
- Publication type:
- Article
Nivolumab in patients with metastatic renal cell carcinoma and chronic hepatitis C virus infection.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 983, doi. 10.1007/s00262-020-02521-y
- By:
- Publication type:
- Article
Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1071, doi. 10.1007/s00262-020-02523-w
- By:
- Publication type:
- Article
Anti-inflammatory microenvironment of esophageal adenocarcinomas negatively impacts survival.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1043, doi. 10.1007/s00262-020-02517-8
- By:
- Publication type:
- Article
Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1001, doi. 10.1007/s00262-020-02520-z
- By:
- Publication type:
- Article
CD1d expression and invariant natural killer T-cell numbers are reduced in patients with upper gastrointestinal cancers and are further impaired by commonly used chemotherapies.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 969, doi. 10.1007/s00262-020-02514-x
- By:
- Publication type:
- Article
Predictive value of positron emission tomography for the prognosis of immune checkpoint inhibitors (ICIs) in malignant tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 927, doi. 10.1007/s00262-020-02515-w
- By:
- Publication type:
- Article
Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1131, doi. 10.1007/s00262-020-02509-8
- By:
- Publication type:
- Article
miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 951, doi. 10.1007/s00262-020-02507-w
- By:
- Publication type:
- Article
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11–13 2018, Milan, Italy.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1141, doi. 10.1007/s00262-020-02502-1
- By:
- Publication type:
- Article
Development and characterization of a novel anti-OX40 antibody for potent immune activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 939, doi. 10.1007/s00262-020-02501-2
- By:
- Publication type:
- Article
Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1015, doi. 10.1007/s00262-020-02495-x
- By:
- Publication type:
- Article
Prostaglandin E2 in a TLR3- and 7/8-agonist-based DC maturation cocktail generates mature, cytokine-producing, migratory DCs but impairs antigen cross-presentation to CD8+ T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 6, p. 1029, doi. 10.1007/s00262-019-02470-1
- By:
- Publication type:
- Article